Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Conference Coverage

Jeffrey M. Cohen, MD
Conference Coverage
Novel TYK2 Inhibitors for Psoriasis
05/03/2023
Psoriasis is undertreated in the United States, which leads to patient dissatisfaction, according to Jeffrey M. Cohen, MD, during his Dermatology Week 2023 session.
Psoriasis is undertreated in the United States, which leads to patient dissatisfaction, according to Jeffrey M. Cohen, MD, during his Dermatology Week 2023 session.
Psoriasis is undertreated in the...
05/03/2023
The Dermatologist

Advertisement

Steven R. Feldman, MD, PhD
Conference Coverage
Epidemiology and Proactive Care in Psoriasis
05/03/2023
Kicking off Spring Dermatology Week 2023, Joel M. Gelfand, MD MSCE, and Steven R. Feldman, MD, PhD, presented their session, “Better Care for Psoriasis Patients.”
Kicking off Spring Dermatology Week 2023, Joel M. Gelfand, MD MSCE, and Steven R. Feldman, MD, PhD, presented their session, “Better Care for Psoriasis Patients.”
Kicking off Spring Dermatology...
05/03/2023
The Dermatologist
doctor with patient
Conference Coverage
Key Insights: Vaccines and Infectious Diseases
04/28/2023
During their session, “Ask the Expert: Infectious Diseases,” presented at the Interdisciplinary Autoimmune Summit, Alexis Ogdie, MD, MSCE, and Kevin Winthrop, MD, MPH, held a discussion on vaccinations in relation to infectious diseases.
During their session, “Ask the Expert: Infectious Diseases,” presented at the Interdisciplinary Autoimmune Summit, Alexis Ogdie, MD, MSCE, and Kevin Winthrop, MD, MPH, held a discussion on vaccinations in relation to infectious diseases.
During their session, “Ask the...
04/28/2023
The Dermatologist
Kaplan G
Conference Coverage
Environmental Effects on IMIDs
04/28/2023
On the third day of the 2023 Interdisciplinary Autoimmune Summit, Gilaad Kaplan, MD, MPH, FCAHS, presented his session, “The Effects of the Environment on Immune-mediated Diseases (IMIDs): Inflammatory Bowel Disease (IBD) as a Case Study.”
On the third day of the 2023 Interdisciplinary Autoimmune Summit, Gilaad Kaplan, MD, MPH, FCAHS, presented his session, “The Effects of the Environment on Immune-mediated Diseases (IMIDs): Inflammatory Bowel Disease (IBD) as a Case Study.”
On the third day of the 2023...
04/28/2023
The Dermatologist

Advertisement

Leonard Calabrese, DO
Conference Coverage
A Forward Look at IMIDs
04/27/2023
Joel M. Gelfand, MD, MSCE; Leonard Calabrese, DO; Adam S. Cheifetz, MD; and Stephen B. Hanauer, MD, joined together in a roundtable discussion to look at the future of immune-mediated inflammatory diseases.
Joel M. Gelfand, MD, MSCE; Leonard Calabrese, DO; Adam S. Cheifetz, MD; and Stephen B. Hanauer, MD, joined together in a roundtable discussion to look at the future of immune-mediated inflammatory diseases.
Joel M. Gelfand, MD, MSCE;...
04/27/2023
The Dermatologist
drugs
Conference Coverage
Steroids and the Treatment of Autoimmune Conditions
04/27/2023
On the second day of the 2023 Interdisciplinary Autoimmune Summit, Stephen B. Hanauer, MD, and Soumya Reddy, MD, reviewed indications for steroids in immune-mediated inflammatory diseases and the efficacy of steroid-sparing therapies.
On the second day of the 2023 Interdisciplinary Autoimmune Summit, Stephen B. Hanauer, MD, and Soumya Reddy, MD, reviewed indications for steroids in immune-mediated inflammatory diseases and the efficacy of steroid-sparing therapies.
On the second day of the 2023...
04/27/2023
The Dermatologist
psoriasis
Conference Coverage
Immune-mediated Inflammatory Diseases: Past and Current Treatments
04/26/2023
Christopher T. Ritchlin, MD, MPH, provided the keynote kickoff for the Interdisciplinary Autoimmune Summit virtual meeting April 26 by addressing advances in the treatment of immune-mediated inflammatory diseases.
Christopher T. Ritchlin, MD, MPH, provided the keynote kickoff for the Interdisciplinary Autoimmune Summit virtual meeting April 26 by addressing advances in the treatment of immune-mediated inflammatory diseases.
Christopher T. Ritchlin, MD,...
04/26/2023
The Dermatologist

Advertisement

Peter Lio
Conference Coverage
JAK Inhibitor Safety for Atopic Dermatitis
04/26/2023
On the first day of the 2023 Interdisciplinary Autoimmune Summit, Peter Lio, MD, FAAD, presented his session, “JAK Inhibitor Safety in the Treatment of Atopic Dermatitis (AD): Evaluating the Long-Term Data.”
On the first day of the 2023 Interdisciplinary Autoimmune Summit, Peter Lio, MD, FAAD, presented his session, “JAK Inhibitor Safety in the Treatment of Atopic Dermatitis (AD): Evaluating the Long-Term Data.”
On the first day of the 2023...
04/26/2023
The Dermatologist
Joel Gelfand, MD
Conference Coverage
Predictions on the Future of Dermatology
04/26/2023
Joel M. Gelfand, MD, MSCE, and Joseph R. Merola, MD, MMSc, explored trends in dermatology practice organization and the impact of drug development, research priorities, and emerging technology on clinical practice.
Joel M. Gelfand, MD, MSCE, and Joseph R. Merola, MD, MMSc, explored trends in dermatology practice organization and the impact of drug development, research priorities, and emerging technology on clinical practice.
Joel M. Gelfand, MD, MSCE, and...
04/26/2023
The Dermatologist
skin of color prurigo nodularis
Conference Coverage
Prurigo Nodularis: Features and Burden of Disease
04/26/2023
Shawn Kwatra, MD, described the clinical features, pathophysiology, and burden of disease in prurigo nodularis.
Shawn Kwatra, MD, described the clinical features, pathophysiology, and burden of disease in prurigo nodularis.
Shawn Kwatra, MD, described the...
04/26/2023
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Current Issue

October 2024
Volume 32
Issue 7
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

News
Alopecia Areata Associated With Sensorineural Hearing Loss
05/05/2023
Researchers aimed to investigate the association between alopecia areata and sensorineural hearing loss by performing a systematic review.
Researchers aimed to investigate the association between alopecia areata and sensorineural hearing loss by performing a systematic review.
Researchers aimed to investigate...
05/05/2023
The Dermatologist
Legal Ease
Recent Development in Compounding Law
09/04/2008
  In two previous articles regarding compounding, I have touched on the intersection of method-of-use patents and compounding, the FDA’s approach toward compounding pharmacies, and DUSA Pharmaceutical’s lawsuits against compounding...
  In two previous articles regarding compounding, I have touched on the intersection of method-of-use patents and compounding, the FDA’s approach toward compounding pharmacies, and DUSA Pharmaceutical’s lawsuits against compounding...
  In two previous...
09/04/2008
The Dermatologist
Chief Medical Editor Message
Black and White Aren’t Always What They Seem
06/12/2023
Things that are black and white have clear, obvious distinctions. In a situation that is black and white, it is easy to see what is right and wrong.
Things that are black and white have clear, obvious distinctions. In a situation that is black and white, it is easy to see what is right and wrong.
Things that are black and white...
06/12/2023
The Dermatologist
Pharmacotherapy Update
Long-Term Follow-Up of Topical Imiquimod Cycle Therapy
09/04/2008
Topical imiquimod 5% cream (Aldara) has been efficacious for treating actinic keratosis (AK) using a variety of treatment regimens, including cycle therapy. Cycle therapy is defined as imiquimod 5% cream three times per week for 4 weeks on,...
Topical imiquimod 5% cream (Aldara) has been efficacious for treating actinic keratosis (AK) using a variety of treatment regimens, including cycle therapy. Cycle therapy is defined as imiquimod 5% cream three times per week for 4 weeks on,...
Topical imiquimod 5% cream...
09/04/2008
The Dermatologist
News
Autoimmune and Inflammatory Diseases and Mental Health Conditions in Alopecia Areata
06/20/2023
Researchers aimed to assess the burden of comorbidities in patients with alopecia areata and its clinical subtypes, alopecia totalis and alopecia universalis, compared with individuals without alopecia areata.
Researchers aimed to assess the burden of comorbidities in patients with alopecia areata and its clinical subtypes, alopecia totalis and alopecia universalis, compared with individuals without alopecia areata.
Researchers aimed to assess the...
06/20/2023
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

The Dermatologist Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Latest Quizzes and Trivia

Atopic dermatitis
Quiz
Pediatric Atopic Dermatitis Management
11/11/2024
1. What alternative therapies does Dr Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr Swanson,...
1. What alternative therapies does Dr Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr Swanson,...
1. What alternative therapies...
11/11/2024
The Dermatologist
Illustration of a T cell
QUIZ
Test Your Knowledge: The Immunology of Alopecia Areata
11/04/2024
11/04/2024
The Dermatologist
psoriasis
Quiz
Long-Term Safety of Risankizumab
10/18/2024
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings regarding the long-term safety of risankizumab?
What were the primary findings...
10/18/2024
The Dermatologist
Brain
Quiz
Barriers to Mental Health Support
10/10/2024
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to...
10/10/2024
The Dermatologist
AD
Quiz
QUIZ: Psoriasis and Atopic Dermatitis: Nonsteroidal Topical Therapies
09/15/2024
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein Gold, how do nonsteroidal topical therapies compare to traditional steroid-based treatments for managing psoriasis and AD?a) They are less effective but safer.b) They are as effective as mid-potency steroids and...
1. According to Dr Linda Stein...
09/15/2024
The Dermatologist
psoriasis
Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
contact dermtitis + Neck + Eczema + rash
Quiz
QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing
07/14/2024
What is a common challenge for patients during the patch testing week?
What is a common challenge for patients during the patch testing week?
What is a common challenge for...
07/14/2024
The Dermatologist
gloves hands
Quiz
Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis
05/30/2024
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview...
05/30/2024
The Dermatologist
Atopic dermatitis
Quiz
Quiz: Atopic Dermatitis Spotlight
05/06/2024
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications...
05/06/2024
The Dermatologist
basal cell carcinoma
Quiz
True or False: Basal Cell Carcinoma on Vermilion Lip
05/01/2024
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the...
05/01/2024
The Dermatologist

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use